Company Analysis
Sign in

TuHURA Biosciences, Inc. (HURA)

Nasdaq: HURA · Pharmaceutical Preparations · Tampa, FL · filing with the SEC since 2010
Full chart Alerts Compare
Grade4.1
◀ Past 4.2● Present 2.9▶ Future 5.2
5 est.
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart

Income statement, as filed

In US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.
Income statement, by fiscal year, newest first
Fiscal yearFY 2025FY 2024FY 2024FY 2023FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period endingDec 31, 2025Dec 31, 2024Jun 30, 2024Dec 31, 2023Jun 30, 2023Jun 30, 2022Jun 30, 2021Jun 30, 2020Jun 30, 2019Jun 30, 2018
Report filedMar 31, 2026Mar 31, 2025Oct 7, 2024·Sep 18, 2023Sep 27, 2022Sep 28, 2021Sep 18, 2020Sep 9, 2019Sep 24, 2018
Revenue00·0······
Research and development20,532,67013,335,3162,663,0009,402,4179,311,00015,173,00011,815,0003,630,000r3,662,056r-7,132,952
General and administrative7,583,6513,873,836r5,788,0004,144,6485,485,0007,509,0009,757,0004,514,000r4,736,440r-4,041,711
Total operating expenses31,795,93917,649,4928,451,00029,764,72014,796,00022,682,00038,166,000r-9,198,000r8,398,496r-11,174,663
Interest expense625,2834,138,301·18,688··30,000···
Interest and investment income136,233361,632·89,673······
Other income (expense), net1,743,962-4,032,814·447,894······
Total non-operating income (expense)··131,000·147,00021,000-132,00072,000r350,275r-36,351
Income before income taxes-30,051,977-21,682,306r·29,300,000······
Income tax expense1,6003,768·0······
Net income including non-controlling interests-30,051,977-21,682,306-8,320,000-29,316,826-14,649,000-22,661,000-38,298,000-9,126,000r-8,048,221-11,138,312
Net income-30,051,977-21,682,306-8,320,000-29,316,826-14,649,000-22,661,000-38,298,000-9,126,000r-8,048,221r11,138,312
Net income to common shareholders-30,060,333-22,649,572-8,501,000-29,316,826-15,019,000-25,131,000-41,504,000-9,143,000r-8,128,652r11,314,548
Earnings per share, basic-0.63-1.21-0.32-2.47-9.27-25.80r-80.00b-43.50rb158.00b271.00rb
Earnings per share, diluted-0.63-1.21·-2.47······
Weighted average shares, basic47,927,19618,662,69026,352,00011,889,1931,620,000974,000r517,720b208,880rb51,494b41,723rb
Weighted average shares, diluted47,927,19618,662,690·11,889,193······
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.Share counts and per-share figures are on the newest report's basis, after the 1-for-50 reverse split.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it soldus-gaap:Revenues
Research and development spent on inventing what it sells nextus-gaap:ResearchAndDevelopmentExpense
General and administrative the cost of running the company itselfus-gaap:GeneralAndAdministrativeExpense
Total operating expenses the running costs togetherus-gaap:OperatingExpenses
Interest expense what its borrowing costus-gaap:InterestExpense
Interest and investment income what its cash and investments earnedus-gaap:InterestIncomeOther
Other income (expense), net gains and costs outside the businessus-gaap:OtherNonoperatingIncomeExpense
Total non-operating income (expense) everything outside the business, togetherus-gaap:NonoperatingIncomeExpense
Income before income taxes profit before taxus-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
Income tax expense tax charged on the period's profitus-gaap:IncomeTaxExpenseBenefit
Net income including non-controlling interests the whole group's profit, minority holders' share includedus-gaap:ProfitLoss
Net income the profit or loss that belongs to the company's shareholdersus-gaap:NetIncomeLoss
Net income to common shareholders what is left for common shareholdersus-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
Earnings per share, basic net income per share outstandingus-gaap:EarningsPerShareBasic
Earnings per share, diluted net income per share, counting every share that could be issuedus-gaap:EarningsPerShareDiluted
Weighted average shares, basic the average count of shares outstandingus-gaap:WeightedAverageNumberOfSharesOutstandingBasic
Weighted average shares, diluted the average count with every share that could be issuedus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
SI Assistanton HURA · research, not advice